Abstract
There is increasing evidence indicating that the expression of histocompatibility antigens is altered in experimental tumors induced in mice as well as in human tumors (1,2,). Two different types of alterations have been described:
-
a)
Total or selective loss of class I molecules (K,D,L or HLA, A,B,C) whose reexpression can in most cases be induced after γIFN treatment. Examples of this are absence of the Kk molecule of Gardner lymphoma (3) or the disappearence of four H-2d antigenic specificities on an H-2d sarcoma (4).
-
These losses may represent an escape route from T cell immunosurveillance or a mechanism to induce UK sensitive tumor targets, (19).
-
b)
The appearance of aberrant class I like molecules which may behave like alloantigens and are capable of triggering an immune response like that seen in allograft rejection (5,6). The aberrant molecules on these clones may be tumor associated transplantation antigen (TATA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
H. Festenstein, F. Garrido. MHC antigens and malignancy. Nature 322 502–503. (1986).
H. Festenstein. The biological consequences of altered MHC expression on tumours. British Medical Bulletin 43,1, 217–227. (1987).
F. Garrido, H. Festenstein, V. Schirrmacher. Further evidence for derepression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature 261–705. (1976).
F. Garrido, M. Pérez, MdD. Torres. Absence of four H-2d antigenic specificities in an H-2 sarcoma. J. of. Immunogenetics 6, 83–86. (1979).
V. Schirrmacher, D. Hübsch, F. Garrido. Syngeneic tumor cells can induce alloreactive T killer cells: A biological role for transplantation antigens. Proc. Natl. Acad. Sci. 77, 9, 5409–5413. (1980)
F. Garrido, M. Pérez, M.D. Torres, E. Garcia-Olivares, P. Ivanyi, V. Schirrmacher. A syngeneic anti tumor serum recognizing a complex H-2 alloantigen. Immunobiol. 156, 110–120. (1979).
H.J. Stauss, R. Linsk, A. Fischer, S. Watts, D. Banasiak, A. Haberman, I. Clark, J. Forman, M. McMillan, H. Schreiber, R.S. Goodenow. Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma. J. of Immunogenetics. 13, 101–111. (1986).
R.S.Goodenow, J.M. Vogel, R.L. Linsk. Histocompatibility antigens on murine tumors. Science 230, 777. (1985).
K. Hui, L. Minamide, N. Padroni, H. Festenstein, F.G. Grosveld. Structural variations in the H-2 genes AXE lymphomas. J. of Immunogenetics 13, 117–121. (1986).
W. Schmidt, G. Noll, D. Bevec, U. Henseling. Aberrant MHC antigens in a sarcoma virus-induced mouse tumour. J. of Immunogenetics. 13, 123–132. (1986).
A. Garrido, M. Pérez, C. Delgado, M.L. Garrido, J. Rojano, I. Algarra, F. Garrido. Influence of class I H-2 gene expression on local tumor growth. Exp. and Clinical Immunogenetics. 3, 98–110 (1986).
L. Eisenbach, S. Segal, M. Feldman. MHC imbalance and metastatic spread in Lewis lung carcinoma clones. International J. of Cancer 32, 113. (1983).
M.L. Garrido, M. Pérez, C. Delgado, J. Rojano, I. Algarra, A. Garrido, F. Garrido. Immunogenicity of H-2 positive and H-2 negative clones of a mouse tumour GR9. J. of Immunogenetics. 13, 159–167. (1986).
F.J. Bonal, E. Pareja, J. Martin, C. Romero, F. Garrido. Repression of class I H-2K, H-2D antigens on GR9 methylcholanthreneinduced tumour cell clones is related to the level of DNA methylation. 13, 179–186. (1986).
A. Caballero, MD. Collado, I. Algarra, A. Garrido, M. Pérez, F.rGarrido. H-2 antigen expression, tumor associated transplantation antigens any anti tumor CTL’s in clones derived from a chemically induced tumours. (in press) (1987).
C. Delgado, A. Garrido, M. Pérez, M.L. Garrido, I. Algarra, F. Garrido. Characterization of the syngeneic anti-tumour response against the GR9 tumour with the production of isoantisera and monoclonal antibodies. J. of Immunogenetics. 13, 169–177. (1986).
A. Watson, F.H. Bach. The role of gp70 in the target antigen recognized by murine leukemia virus immune cytotoxic T-lymphocytes. Int. J. Cancer. 26, 483. (1980).
E. Pareja, E. Canadas, C. Romero, J. Martin M.J. Mialdea, F. Garrido. MHC-DNA class I gene transfection and expression in a murine class I negative tumour cell clone. Inmunologia (in press). (1987).
M. Pérez, T. Cabrera, M.A. Lopez Nevot, M. Gomez, F. Peran, F. Garrido. Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma. J.of Immunogenetics. 13, 247–253
H.G. Ljunggren, K. Kärre. Experimental strategies and interpretations in the analysis of changes in MHC gene expression during tumour progression: opposing influences of T cell natural killer cell mediated resistance. J. of Immunogenetics. 13, 141–151. (1986)
M.A. Lopez Nevot, E. Garcia, E. Pareja, F.J. Bonal, J. Martin, F. Differential expression of HLA class I and II antigens in primary and metastatic melanomas. J. of Immunogenetics. 13, 219–227. (1986).
J. Gutierrez, M.A. Lopez Nevot, T. Cabrera, R. Oliva, J. Esquivias F. Ruiz-Cabello, F. Garrido. Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: Relation with malignancy and invasiveness. Clin. and Exp. Immunogenetics (in press. (1987).
M. Pérez, A. Garrido, I. Algarra, F. Garrido. Different H-2 phenotypes in clones derived from a new BALB/c solid tumor. Its relevance for local tumor growth. Inmunologia. 4,2, 60–69. (1985).
P.I. Schrier, R. Bernards, R.T.M.J. Vaessen, A. Houweling, A.J. Van Der Eb. Expression of class I major histocompatibility antigens swiched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature. 305, 771. (1983).
F. Momburg, P. Möller, G. Moldenhauer, G.J. Hämmerling. Loss of HLA-A,B,C, in colorectal carcinoma is related to the degree of de-differentiation. J. of Immunogenetics. 13, 195–199. (1986).
F. Ruiz-Cabello, M.A. Lopez Nevot, J. Gutierrez, A. Ferron, F. Esteban, C. Rivas, M.A. Piris, F. Garrido. Phenotypic expression of histocompatibility antigens in human primary tumors and metastases. Cancer Research. (in press). (1987).
M.A. Lopez Nevot, T. Cabrera, B. de la Higuera, F. Ruiz-Cabello F. Garrido. Production and characterization of monoclonal antibodies against human leukaemia cells. Inmunologia. 5, 2. 51–59. (1986).
T. Cabrera, F. Ruiz-Cabello, M.A. Lopez Nevot, B. de la Higuera, M. Sanchez, F. Garrido. Characterization of monoclonal antibodies directed against HLA class II molecules. Hybridoma. 5,3, 191–197. (1986).
A. Ziegler, B. Uchanska-Ziegler, G. Rosenfelder, D.G. Braun, P. Wernet. Heterogeneity of established human hematopoietic cell lines: Surface antigens detected by monoclonal antibodies and glycosphilipid patterns. In: Leukaemia markers. Proceedings of the leukaemia marker conference held in Vienna. Academic Press. 137. (1981).
A.J. Watson, R. Demars, I.S. Trowbridge, F.H. Bach. Detection of a novel human HLA antigen. Nature. 304, 358–361. (1983).
D.J. Ruiter, W. Bergman, K. Welvaart, E. Scheffer, W.A. van Vloten C. Russo, S. Ferrone. Immunohistological analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. Cancer Res. 44, 3930. (1984).
E.B. Bröcker, L. Suter, J. BrUggen, D.J. Ruiter, E. Macher, C. Sorg. Phenotypic dynamics of tumor progression in human malignant melanoma. Int. J. of Cancer. 36, 29. (1985).
F. Ruiz-Cabello, M.A. Lopez Devot, F. Garrido. MHC class I and II gene expression on human tumors. Cancer Metastasis, Bolonia, Italy Plenum Publishing Corporation. (In press). May 13–15 (1987).
P.L. Stern, N. Beresford, S.M. Bell, S. Thompson, K. Jones, A. Mellor. Murine embryonal carcinoma cells express class I MHC like antigens. J. of Immunogenet. 13, 133. (1986).
G.J. Hämmeling, D. Klar, S. Katzav, S. Segal, M. Feldman, R. Wallich, A. Hämmerling. Manipulation of metastasis and tumor growth by transfection with histocompatibility class I genes. J. of Immunogenet. 13, 153. (1986).
F. Garrido, V. Schirrmacher, H. Festenstein. H-2 like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature. 259, 5540, 228–230. (1976).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Garrido, F. (1987). The Biological Implications of the Abnormal Expression of Histocompatibility Antigens on Murine and Human Tumors. In: David, C.S. (eds) H-2 Antigens. NATO ASI Series, vol 144. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0764-9_60
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0764-9_60
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0766-3
Online ISBN: 978-1-4757-0764-9
eBook Packages: Springer Book Archive